Skip to Content

Somatuline Depot

In the US, Somatuline Depot (lanreotide systemic) is a member of the drug class somatostatin and somatostatin analogs and is used to treat Acromegaly, Carcinoid Syndrome and Neuroendocrine Carcinoma.

US matches:

Ingredient matches for Somatuline Depot


Lanreotide acetate (a derivative of Lanreotide) is reported as an ingredient of Somatuline Depot in the following countries:

  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.